The Food and Drug Administration today recommended medical device manufacturers, health care providers and patients take certain actions to reduce the risk that a remote attacker could exploit a set of cybersecurity vulnerabilities to control a medical device or prevent it from functioning. The agency to date has not received any adverse event reports associated with the vulnerabilities, announced in a July advisory from the Department of Homeland Security. The vulnerabilities exist in IPnet, a third-party software component that supports network communications between computers. The software is part of several operating systems and may be used in a wide range of medical and industrial devices.
 

Headline
The Food and Drug Administration is seeking feedback on a discussion paper released Nov. 6 on the benefits and risks of robotic medical devices with autonomous…
Headline
Federal agencies Nov. 5 issued a bulletin saying that they are aware of malicious cyber activity targeting industrial refrigeration and cold chain monitoring…
Headline
The Food and Drug Administration has identified Class I recalls of two products: certain platelet factor 4 radioimmunoassay products by Instrumentation…
Headline
The AHA will host a webinar Nov. 3 at 1 p.m. ET to discuss the cybersecurity, compliance and operational risks that can emerge when end-of-life technology is…
Headline
The Department of Justice Oct. 13 announced a series of actions disrupting a scheme by the North Korean government that involved placing remote IT workers in U…
Headline
A joint advisory issued Oct. 20 by U.S. and international agencies warns of recent activity by the SafePay Ransomware group. The group has been active since…